دورية أكاديمية
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
| العنوان: | Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival |
|---|---|
| المؤلفون: | Morra, A., Schreurs, M.A.C., Andrulis, I.L., Anton‐Culver, H., Augustinsson, A., Beckmann, M.W., Behrens, S., Bojesen, S.E., Bolla, M.K., Brauch, H., Broeks, A., Buys, S.S., Camp, N.J., Castelao, J.E., Cessna, M.H., Chang‐Claude, J., Chung, W.K., Colonna, S.V., Couch, F.J., Cox, A., Cross, S.S., Czene, K., Daly, M.B., Dennis, J., Devilee, P., Dörk, T., Dunning, A.M., Dwek, M., Easton, D.F., Eccles, D.M., Eriksson, M., Evans, D.G., Fasching, P.A., Fehm, T.N., Figueroa, J.D., Flyger, H., Gabrielson, M., Gago‐Dominguez, M., García‐Closas, M., García‐Sáenz, J.A., Genkinger, J., Grassmann, F., Gündert, M., Hahnen, E., Haiman, C.A., Hamann, U., Harrington, P.A., Hartikainen, J.M., Hoppe, R., Hopper, J.L., Houlston, R.S., Howell, A., Jakubowska, A., Janni, W., Jernström, H., John, E.M., Johnson, N., Jones, M.E., Kristensen, V.N., Kurian, A.W., Lambrechts, D., Le Marchand, L., Lindblom, A., Lubiński, J., Lux, M.P., Mannermaa, A., Mavroudis, D., Mulligan, A.M., Muranen, T.A., Nevanlinna, H., Nevelsteen, I., Neven, P., Newman, W.G., Obi, N., Offit, K., Olshan, A.F., Park‐Simon, T., Patel, A.V., Peterlongo, P., Phillips, K., Plaseska‐Karanfilska, D., Polley, E.C., Presneau, N., Pylkäs, K., Rack, B., Radice, P., Rashid, M.U., Rhenius, V., Robson, M., Romero, A., Saloustros, E., Sawyer, E.J., Schmutzler, R.K., Schuetze, S., Scott, C., Shah, M., Smichkoska, S., Southey, M.C., Tapper, W.J., Teras, L.R., Tollenaar, R.A.E.M., Tomczyk, K., Tomlinson, I., Troester, M.A., Vachon, C.M., van Veen, E.M., Wang, Q., Wendt, C., Wildiers, H., Winqvist, R., Ziogas, A., Hall, P., Pharoah, P.D.P., Adank, M.A., Hollestelle, A., Schmidt, M.K., Hooning, M.J. |
| بيانات النشر: | Wiley |
| سنة النشر: | 2023 |
| المجموعة: | White Rose Research Online (Universities of Leeds, Sheffield & York) |
| الوصف: | Background Breast cancer (BC) patients with a germline CHEK2 c.1100delC variant have an increased risk of contralateral BC (CBC) and worse BC-specific survival (BCSS) compared to non-carriers. Aim To assessed the associations of CHEK2 c.1100delC, radiotherapy, and systemic treatment with CBC risk and BCSS. Methods Analyses were based on 82,701 women diagnosed with a first primary invasive BC including 963 CHEK2 c.1100delC carriers; median follow-up was 9.1 years. Differential associations with treatment by CHEK2 c.1100delC status were tested by including interaction terms in a multivariable Cox regression model. A multi-state model was used for further insight into the relation between CHEK2 c.1100delC status, treatment, CBC risk and death. Results There was no evidence for differential associations of therapy with CBC risk by CHEK2 c.1100delC status. The strongest association with reduced CBC risk was observed for the combination of chemotherapy and endocrine therapy [HR (95% CI): 0.66 (0.55–0.78)]. No association was observed with radiotherapy. Results from the multi-state model showed shorter BCSS for CHEK2 c.1100delC carriers versus non-carriers also after accounting for CBC occurrence [HR (95% CI): 1.30 (1.09–1.56)]. Conclusion Systemic therapy was associated with reduced CBC risk irrespective of CHEK2 c.1100delC status. Moreover, CHEK2 c.1100delC carriers had shorter BCSS, which appears not to be fully explained by their CBC risk. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | text |
| اللغة: | English |
| العلاقة: | https://eprints.whiterose.ac.uk/201368/1/Cancer%20Medicine%20-%202023%20-%20Morra%20-%20Association%20of%20the%20CHEK2%20c%201100delC%20variant%20%20radiotherapy%20%20and%20systemic%20treatment%20with.pdfTest; Morra, A. orcid.org/0000-0003-4983-7883 , Schreurs, M.A.C. orcid.org/0000-0002-1826-5344 , Andrulis, I.L. et al. (114 more authors) (2023) Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer Medicine. ISSN 2045-7634 |
| الإتاحة: | https://eprints.whiterose.ac.uk/201368Test/ https://eprints.whiterose.ac.uk/201368/1/Cancer%20Medicine%20-%202023%20-%20Morra%20-%20Association%20of%20the%20CHEK2%20c%201100delC%20variant%20%20radiotherapy%20%20and%20systemic%20treatment%20with.pdfTest |
| حقوق: | cc_by_4 |
| رقم الانضمام: | edsbas.408D16CA |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |